All catastrophes are not catastrophic antiphospholipid syndrome
暂无分享,去创建一个
[1] M. Makris,et al. Vaccine-induced immune thrombotic thrombocytopenia , 2021, The Lancet Haematology.
[2] M. Crowther,et al. A systematic review of the association between anti-β-2 glycoprotein I antibodies and APS manifestations , 2021, Blood advances.
[3] J. Connors,et al. Heparin Resistance - Clinical Perspectives and Management Strategies. , 2021, The New England journal of medicine.
[4] A. Greinacher,et al. Spontaneous HIT syndrome: Knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia. , 2021, Thrombosis research.
[5] Qi Zhou,et al. Mechanism of thrombocytopenia in COVID-19 patients , 2020, Annals of Hematology.
[6] M. Petri,et al. Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS. , 2019, Blood.
[7] M. Ozelo,et al. Prolonged APTT of unknown etiology: A systematic evaluation of causes and laboratory resource use in an outpatient hemostasis academic unit , 2019, Research and practice in thrombosis and haemostasis.
[8] D. Fries,et al. Influence of factor XII deficiency on activated partial thromboplastin time (aPTT) in critically ill patients , 2019, Journal of Thrombosis and Thrombolysis.
[9] Gagandeep Singh,et al. Unseen face of varicella-zoster infection in adults , 2016, Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine.
[10] J. Knight,et al. Treatment of catastrophic antiphospholipid syndrome. , 2016, Current opinion in rheumatology.
[11] T. Ortel,et al. How I treat catastrophic thrombotic syndromes. , 2015, Blood.
[12] D. Gilden,et al. Editorial commentary: varicella zoster virus infection: generally benign in kids, bad in grown-ups. , 2014, Clinical Infectious Diseases.
[13] O. Rawley,et al. Elevated factor VIII levels and risk of venous thrombosis , 2012, British journal of haematology.
[14] A. Wolberg,et al. Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice. , 2011, Blood.
[15] J. Filipovský,et al. Laboratory Evaluation of Antiphospholipid Antibodies in Patients With Venous Thromboembolism , 2010, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
[16] E. L. Luning Prak,et al. The ITP syndrome: pathogenic and clinical diversity. , 2009, Blood.
[17] M. Galli,et al. Clinical Utility of Laboratory Tests Used to Identify Antiphospholipid Antibodies and to Diagnose the Antiphospholipid Syndrome , 2008, Seminars in thrombosis and hemostasis.
[18] T. Lecompte,et al. Anti‐protein S antibodies following a varicella infection: detection, characterization and influence on thrombin generation , 2005, Journal of thrombosis and haemostasis : JTH.
[19] M. Manco‐Johnson,et al. The Varicella-Autoantibody Syndrome , 2001, Pediatric Research.
[20] K. Kavaklı,et al. Lupus anticoagulant and protein S deficiency in a child who developed disseminated intravascular coagulation in association with varicella. , 2001, The Turkish journal of pediatrics.
[21] F. Rosendaal,et al. High levels of factor IX increase the risk of venous thrombosis. , 2000, Blood.
[22] Fabris,et al. Autoimmune thrombocytopenia (AITP) and thyroid autoimmune disease (TAD): overlapping syndromes? , 1998, Clinical and experimental immunology.
[23] J. R. Mayer,et al. Varicella-Associated Thrombocytopenia: Autoantibodies against Platelet Surface Glycoprotein V , 1996, Pediatric Research.
[24] A. Nayer,et al. Catastrophic antiphospholipid syndrome: a clinical review. , 2014, Journal of nephropathology.
[25] J. George,et al. Drug-induced thrombocytopenia: pathogenesis, evaluation, and management. , 2009, Hematology. American Society of Hematology. Education Program.
[26] C. Kitchens. Thrombocytopenia and thrombosis in disseminated intravascular coagulation (DIC). , 2009, Hematology. American Society of Hematology. Education Program.
[27] Ricard Cervera,et al. Clinical and epidemiological aspects in the antiphospholipid syndrome. , 2003, Immunobiology.